Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
The New England journal of medicine.
Times cited: 91
- Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder. Journal of translational medicine. 2014 Academic Article GET IT
- Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PloS one. 2013 Academic Article GET IT
- Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Information Resource GET IT
- c-Met ectodomain shedding rate correlates with malignant potential. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT